Search

everythinglearnresearchcommunity

for

Search:↓

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Anabolic steroid users may face higher risk of severe COVID-19.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Finasteride helps induce ovulation in nonresponder PCOS women.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Stromal Vascular Fraction treatment increases hair density and thickness, making it a safe and effective treatment for Androgenetic Alopecia.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

The document is a detailed medical reference on skin and genetic disorders.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.